Article
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
Journal of the National Cancer Institute - 6 Apr 2011
Barone Ines, Brusco Lauren, Gu Guowei, Selever Jennifer, Beyer Amanda, Covington Kyle R, Tsimelzon Anna, Wang Tao, Hilsenbeck Susan G, Chamness Gary C, Andò Sebastiano, Fuqua Suzanne A W
Abstract excerpt
BACKGROUND: Estrogen receptor (ER) α is a successful therapeutic target in breast cancer, but patients eventually develop resistance to antiestrogens such as tamoxifen. METHODS: To identify genes whose expression was associated with the development of tamoxifen resistance and metastasis, we used microarrays to compare gene expression in four primary tumors from tamoxifen-treated patients whose breast cancers did...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
